Number of companies
Total sum of acquisitions in CHF (bn)
Roche
49
84.4
Novartis
45
120.7
Pfizer
30
373.9
Merck SD
28
69.5
GSK
21
21.5
Sanofi
22
130.6
Johnson & Johnson
29
60.1
Gilead
16
30.3
Eli Lilly
15
27.4
AstraZeneca
12
11.7
Takeda
10
108.7
Bayer
14
80
Teva Pharmaceutical
8
52.1
Biogen Idec
6
1.2
Abbvie
5
88.5
Novo Nordisk
5
1.4
Main acquisitions made by the 16 major companies that have approved a drug in Switzerland over the last two years.